Skip to content
Screener

Erasca, Inc. ERAS Accretion (Amortization) of Discounts and Premiums, Investments

Accretion (Amortization) of Discounts and Premiums, Investments at other companies

Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
$4.33M-44.0%
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
$1.21M-67.9%
Eikon Therapeutics, Inc. logo
Eikon Therapeutics, Inc.EIKN

Other financials

Income statement

See full
Operating income-$187.9M-427%
Net income-$183.4M-492%
EPS (diluted)-$0.60-445%

Balance sheet

See full
Cash & equivalents$47.3M-33.0%
Total debt$46.0M-9.6%
Total equity$393.5M-1.5%
Total assets$461.2M-2.1%

Cash flow

See full
Operating cash flow-$27.4M+13.2%
CapEx$36.0K-56.6%
Free cash flow-$27.4M+13.3%

Valuation

See full
Market cap$6.39B+1,424%
Enterprise value$6.39B+1,487%

Returns & leverage

See full
Return on equity-69.9%+77.1pp
Debt / equity0.1×0.0×
Current ratio9.5×-2.8×

Where this comes from

Reported directly by Erasca, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments.

The source filing: Erasca, Inc.’s 10-Q, filed May 11, 2026.

Filed
May 11, 2026, 4:13 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-216788
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Depreciation and amortization723822
Stock-based compensation expense8,4606,713
In-process research and development expenses150,000
Accretion on marketable securities, net(746)(1,986)
Realized gain from sales of marketable securities, net(47)
Changes in operating assets and liabilities:
Prepaid expenses and other current and long-term assets175459
Accounts payable1,1821,794

Item 1. Financial Statements.

FAQ

What is Erasca, Inc.'s accretion (amortization) of discounts and premiums, investments?
Erasca, Inc. (ERAS) reported accretion (amortization) of discounts and premiums, investments of $746K in Q1 2026.
How has Erasca, Inc.'s accretion (amortization) of discounts and premiums, investments changed year-over-year?
Erasca, Inc.'s accretion (amortization) of discounts and premiums, investments decreased by 62.4% year-over-year, from $1.99M to $746K.
What is the long-term trend for Erasca, Inc.'s accretion (amortization) of discounts and premiums, investments?
Over 4 years (2021 to 2025), Erasca, Inc.'s accretion (amortization) of discounts and premiums, investments has grown at a 162.0% compound annual growth rate (CAGR), from -$108K to $5.09M.
What does accretion (amortization) of discounts and premiums, investments mean?
Reflects the non-cash adjustment to the carrying value of investment securities held by the company, accounting for the difference between the purchase price and the face value of debt instruments. This adjustment aligns the interest income recognized with the effective interest rate method over the life of the investment. It serves as a reconciliation item to bridge net income with actual cash flows generated from investment activities.

Ask your AI about Erasca, Inc.'s accretion (amortization) of discounts and premiums, investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude